Machine learning in a real-world PFO study: analysis of data from multi-centers in China.


Journal

BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682

Informations de publication

Date de publication:
24 11 2022
Historique:
received: 25 08 2022
accepted: 14 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

The association of patent foreman ovale (PFO) and cryptogenic stroke has been studied for years. Although device closure overall decreases the risk for recurrent stroke, treatment effects varied across different studies. In this study, we aimed to detect sub-clusters in post-closure PFO patients and identify potential predictors for adverse outcomes. We analyzed patients with embolic stroke of undetermined sources and PFO from 7 centers in China. Machine learning and Cox regression analysis were used. Using unsupervised hierarchical clustering on principal components, two main clusters were identified and a total of 196 patients were included. The average age was 42.7 (12.37) years and 64.80% (127/196) were female. During a median follow-up of 739 days, 12 (6.9%) adverse events happened, including 6 (3.45%) recurrent stroke, 5 (2.87%) transient ischemic attack (TIA) and one death (0.6%). Compared to cluster 1 (n = 77, 39.20%), patients in cluster 2 (n = 119, 60.71%) were more likely to be male, had higher systolic and diastolic blood pressure, higher body mass index, lower high-density lipoprotein cholesterol and increased proportion of presence of atrial septal aneurysm. Using random forest survival (RFS) analysis, eight top ranking features were selected and used for prediction model construction. As a result, the RFS model outperformed the traditional Cox regression model (C-index: 0.87 vs. 0.54). There were 2 main clusters in post-closure PFO patients. Traditional cardiovascular profiles remain top ranking predictors for future recurrence of stroke or TIA. However, whether maximizing the management of these factors would provide extra benefits warrants further investigations.

Identifiants

pubmed: 36434650
doi: 10.1186/s12911-022-02048-5
pii: 10.1186/s12911-022-02048-5
pmc: PMC9694545
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

305

Subventions

Organisme : Guangdong Medical Association Program
ID : H022018002
Organisme : Scientific Program of Guangdong Provincial People's Hospital
ID : 2016dzx03

Informations de copyright

© 2022. The Author(s).

Références

Stroke. 2021 Jan;52(1):181-189
pubmed: 33297865
Stroke. 2000 Aug;31(8):1877-81
pubmed: 10926950
N Engl J Med. 2017 Sep 14;377(11):1033-1042
pubmed: 28902580
Neurology. 2018 Jul 3;91(1):e8-e18
pubmed: 29875217
Am J Cardiol. 2018 Jun 1;121(11):1393-1399
pubmed: 29680170
N Engl J Med. 2012 Mar 15;366(11):991-9
pubmed: 22417252
N Engl J Med. 2017 Sep 14;377(11):1022-1032
pubmed: 28902590
Cochrane Database Syst Rev. 2018 Jul 19;7:CD007858
pubmed: 30024023
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20
pubmed: 25147037
Eur J Neurol. 2021 Jan;28(1):192-201
pubmed: 32918305
N Engl J Med. 1988 May 5;318(18):1148-52
pubmed: 3362165
JAMA Neurol. 2020 Jul 1;77(7):878-886
pubmed: 32282016
Med J Aust. 2021 Jul;215(2):89-93
pubmed: 34218432
J Am Coll Cardiol. 2018 May 22;71(20):2335-2342
pubmed: 29544871
J Am Coll Cardiol. 2018 Mar 6;71(9):1035-1043
pubmed: 29495983
Front Cardiovasc Med. 2022 Jul 08;9:735906
pubmed: 35872897
Stroke. 2021 Jul;52(7):e364-e467
pubmed: 34024117
N Engl J Med. 2017 Sep 14;377(11):1011-1021
pubmed: 28902593
N Engl J Med. 2013 Mar 21;368(12):1083-91
pubmed: 23514285
JAMA. 2021 Dec 14;326(22):2277-2286
pubmed: 34905030
JACC Cardiovasc Imaging. 2010 Jul;3(7):749-60
pubmed: 20633854
Neurology. 2013 Aug 13;81(7):619-25
pubmed: 23864310
N Engl J Med. 2013 Mar 21;368(12):1092-100
pubmed: 23514286

Auteurs

Dongling Luo (D)

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan 2Nd Road, Guangzhou, 510080, Guangdong, China.

Ziyang Yang (Z)

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan 2Nd Road, Guangzhou, 510080, Guangdong, China.

Gangcheng Zhang (G)

Zhongnan Hospital of Wuhan University, Wuhan, China.

Qunshan Shen (Q)

Wuhan Asian Heart Hospital, Wuhan, China.

Hongwei Zhang (H)

Hubei Huiyi Cardiovascular Center, Enshi, Hubei, China.

Junxing Lai (J)

Jiang Men Central Hospital, Jiangmen, Guangdong, China.

Hui Hu (H)

The First People's Hospital of Foshan, Foshan, Guangdong, China.

Jianxin He (J)

General Hospital of Southern Theatre Command of PLA, Guangzhou, China.

Shulin Wu (S)

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan 2Nd Road, Guangzhou, 510080, Guangdong, China. doctorwushulin@163.com.

Caojin Zhang (C)

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan 2Nd Road, Guangzhou, 510080, Guangdong, China. gdzcjpaper@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH